Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Demyelinating and thrombotic diseases of the central nervous system: common pathogenic and triggering factors.
A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses.
[Electrophysiological examination of multiple sclerosis].
Daily fingolimod administration may cause lymphopenia but alternate-day administration may be too little to inhibit disease activity.
Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis.
Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Efficacy of Schwann Cell (SC) transplantation for spinal cord repair is improved with combinatorial strategies.
Acute demyelinating disorders of the central nervous system.
Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis.
Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed.
Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature.
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Neural stem/progenitor cells differentiate into oligodendrocytes, reduce inflammation, and ameliorate learning deficits after transplantation in a mouse model of traumatic brain injury.
Tumour suppressor death-associated protein kinase targets cytoplasmic HIF-1α for Th17 suppression.
Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.
Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4.
Determinants of Psychosocial Difficulties Experienced by Persons with Brain Disorders: Towards a 'Horizontal Epidemiology' Approach.
Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
Infectious and noninfectious granulomatosis in patient with multiple sclerosis: diagnostic dilemmas and followup.
A Review of Safety-Related Pregnancy Data Surrounding the Oral Disease-Modifying Drugs for Multiple Sclerosis.
The Advances in Neurobiology.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
Pages
« first
‹ previous
…
713
714
715
716
717
718
719
720
721
…
next ›
last »